ValueQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSelling/general/admin expenses9.77 M13.3 M15.47 M15.9 M17.89 M62.56 MResearch & development1.31 M1.26 M1.57 M1.79 M1.71 M6.33 MOperating income7.11 M4.77 M3.19 M4.24 M4.09 M16.28 MNon-Operating Income, Total——————Interest expense, net of interest capitalized——————Non-Operating Income, excl. Interest Expenses——————Unusual income/expense——————Pretax income7.48 M5.23 M3.74 M4.8 M4.42 M18.19 MEquity in earnings——————Taxes305 K168 K128 K222 K292 K810 KNon-controlling/minority interest——————After tax other income/expense-18 K-13 K-13 K-15 K-18 K-59 KNet income before discontinued operations7.18 M5.06 M3.61 M4.58 M4.13 M17.38 MDiscontinued operations——————Net income7.18 M5.06 M3.61 M4.58 M4.13 M17.38 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders7.18 M5.06 M3.61 M4.58 M4.13 M17.38 MBasic earnings per share (Basic EPS)0.10.070.050.060.040.22Diluted earnings per share (Diluted EPS)0.10.060.040.050.050.2Average basic shares outstanding75.93 M77.81 M79.25 M79.78 M79.18 M316.02 MDiluted shares outstanding78.13 M83.23 M86.24 M86.62 M85.44 M341.53 MEBITDA7.41 M4.97 M3.42 M4.51 M4.4 M17.29 MEBIT7.11 M4.77 M3.19 M4.24 M4.09 M16.28 MCost of revenue10.93 M11.15 M10.89 M12.06 M12.13 M46.23 MOther cost of goods sold——————Depreciation & amortization (cash flow)302 K195 K233 K270 K312 K1.01 M
Niagen Bioscience Inc
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.